Delivery Order SPE2DB22D3016-SPE2DB25FAVM7
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 15 mg/0.5 ml pens. The contract has a firm fixed price of $4,590.11 and a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a ceiling value of $2,629.79 and a period of performance ending on May 1, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (Tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed price of $5,301.99 and a period of performance through April 11, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,418.73, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The contract has a firm fixed price of $1,632.54 and a period of performance ending on May 5, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens, a diabetes medication. The contract is a firm fixed price delivery order with a ceiling value of $1,843.66 and a period of performance through May 1, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $29,500.48, is for the supply of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,558.18, is for the supply of the diabetes medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The delivery order has a ceiling value of $1,052 and a completion date of September 24, 2024. This award is a firm fixed-price contract and is not set aside for any special category of business. AmerisourceBergen holds a larger...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $12,871.11 firm-fixed-price contract is for the delivery of the diabetes medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen is a critical supplier of pharmaceutical products and medical supplies to various government...